Skip to main content

Diabetes complications and comorbidities: Hypoglycemia

Journal articles and book chapters

05-25-2018 | Diabetes self-management | Article

Type 1 diabetes self-management from emerging adulthood through older adulthood

McCarthy MM, Grey M. Diabetes Care 2018. doi: 10.2337/dc17-2597

05-24-2018 | Gliclazide | Review | Article

The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents

Colagiuri S et al. Diabetes Res Clin Prac 2018. doi: 10.1016/j.diabres.2018.05.028

05-19-2018 | Liraglutide (T2DM) | Article

Retrospective analysis of an insulin-to-liraglutide switch in patients with type 2 diabetes mellitus

Introduction: Insulin and the GLP-1 receptor agonist liraglutide are both effective in reaching glycemic targets. The efficacy of an insulin-to-liraglutide switch in an obese population with concurrent use of sulfonylurea and metformin is unknown. We assessed the efficacy and determinants of success of an insulin-to-liraglutide switch in these patients.

05-18-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

Person holding sweeteners

05-15-2018 | Diet | Article

Glycemic impact of non-nutritive sweeteners: A systematic review and meta-analysis of randomized controlled trials

Nichol AD, Holle MJ, An R. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0170-6

05-10-2018 | Devices and technology | Review | Article

Diabetes care in the digital era: A synoptic overview

Fatehi F, Menon A, Bird D. Curr Diab Rep 2018; 18: 38. doi: 10.1007/s11892-018-1013-5

05-09-2018 | Liraglutide (T2DM) | Article

Real-world clinical effectiveness and cost savings of liraglutide versus sitagliptin in treating type 2 diabetes for 1 and 2 years

Li Q et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0432-2

05-08-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: Do oral agents have a place?

Corcoy R et al. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.015

05-08-2018 | Type 2 diabetes | Review | Article

Type 2 diabetes in youth: New lessons from the SEARCH study

Jensen ET, Dabelea D. Curr Diab Rep 2018; 18: 36. doi: 10.1007/s11892-018-0997-1

05-04-2018 | Gestational diabetes | Article

The post-HAPO situation with gestational diabetes: The bright and dark sides

Lapolla A, Metzger BE. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1146-7

05-03-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: The new insulins

Toledano Y, Hadar E, Hod M. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.035

05-01-2018 | Glyburide | Article

Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: A randomized clinical trial

Sénat MV et al. JAMA 2018; 319: 1773–1780. doi: 10.1001/jama.2018.4072

04-30-2018 | Insulin degludec | Article

DEVOTE 5: Evaluating the short-term cost-utility of insulin degludec versus insulin glargine U100 in basal–bolus regimens for type 2 diabetes in the UK

Pollock RF et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0430-4

04-28-2018 | Heart failure | Review | Article

SGLT2 inhibition and heart failure: Current concepts

Custodio JS et al. Heart Fail Rev 2018; 23: 409–418. doi: 10.1007/s10741-018-9703-2

04-23-2018 | Gestational diabetes | Article

Neonatal hypoglycemia following diet-controlled and insulin-treated gestational diabetes mellitus

Voormolen et al. Diabetes Care 2018. doi: 10.2337/dc18-0048